If you would like your news to be listed here, please fill in the form to upload your information. Please note, we will only post news related to the life sciences.

Find us on

[Evènement] Sport et Technologie en conférence à l’Espace Création le 7 juin

Comment soutenir et quel est l’impact de l’innovation dans le domaine du sport ? Quel...

Indice de compétitivité: la Suisse dégringole …

Les cinq pays les plus compétitifs au monde sont restés les mêmes, mais leurs places...

Incubée à UniverCité : be.care décroche un partenariat avec Swiss Timing (Swatch Group)

Active dans le domaine du monitoring du sportif, la société be.care, installée à UniverCité, vient...

Si les génériques avaient un prix de référence

Les médicaments génériques coûtent plus cher en Suisse qu’à l’étranger. Pour éviter que les assurés...

Innosquare HES-SO / Fondation Inartis: “C’est exactement ça qui est important : De créer un spirit d’innovation dans notre pays”

“C’est exactement ça qui est important : De créer un spirit d’innovation dans notre pays” commente...

Offre spéciale aux lecteurs de Republic-of-innovation : prolongez la lecture de PME Magazine, gratuitement

Vous avez aimé l’article de PME Magazine sur Innosquare. LIEN (https://www.pme.ch/entreprises/2018/04/25/pepites-attendent-labos) Prolongez la lecture en...

Le clin d’oeil de PECUB: Achat de génie, vente d’intelligence

Si toutes les structures de recherche et développement du monde se donnaient la main, ou...

IPO à 165 millions pour Polyphor

La cotation des actions de l’entreprise biopharmaceutique Polyphor démarre ce mardi. Il s’agit de la...

Bientôt des médicaments à la Coop et à la Migros?

Va-t-on pouvoir un jour trouver un rayon médicaments entre le rayon pain et celui des...

Des licences pour faire baisser le prix des médicaments en Suisse

Le Conseil fédéral doit recourir à des licences obligatoires pour faciliter l’accès aux génériques malgré...

Kinntek chooses Pryv

Kinntek, announces that it has chosen Pryv to extend its breakthrough hand rehabilitation interactive platform with advanced privacy-preserving capacity.

Oculis raises CHF20 million and moves to Switzerland

Oculis, a clinical-stage biotechnology company focused on the development of non-invasive topical treatment for back-of-the-eye diseases, announced it has successfully closed a Series B financing round of CHF 20 million. In conjunction with the financing, Oculis is re-locating its corporate headquarters to Lausanne.

14ème édition du Prix à l’innovation du canton de Fribourg

Fribourg recherche les entreprises et les start-up les plus innovantes

Swiss BioInformatics Institute celebrates its 20th anniversary

BIOINFORMATICS, A SWISS PRIDE - 20 YEARS OF SERVICE TO THE LIFE SCIENCES AND HEALTH

EspeRare gains rights to relaunch late stage development for a rare genetic disease

EspeRare is delighted to announce that it has concluded an important agreement with Edimer Pharmaceuticals.

SimplicityBio - Sales Manager position now open

The Swiss based company, founded in 2015, active in the discovery of novel medical biomarkers by means of patented bioinformatics machine-learning platform BOSS, is looking for a Sales Manager.

Retraites Populaires and Biopôle SA launch the first life sciences incubator in Canton of Vaud

9,100 m2 building, funded and constructed by Retraites Populaires on the site of Biopôle, a leading Swiss life science park.

BioFoundry - Open Insulin Project - Call for Partnering Proposals

The Open Insulin mouvement was started in California with the intention of bringing the price of insulin down.

Anergis and Mymetics Start Research Collaboration Project

Mymetics Corporation (OTCQB:MYMX), a pioneer and leader in the research and development of virosome-based vaccines, and Anergis SA, a company developing Contiguous Overlapping Peptides (COPs) for ultra-fast allergy immunotherapy, announced that Mymetics SA, the Swiss subsidiary of Mymetics Corporation and Anergis SA have entered into a Research Collaboration project.

Gene Predictis - Tests génétiques pour prévenir les risques liés aux effets adverse

Des tests pour réduire les risques d'effets nocifs liés aux médicaments et à la nutrition. Un article de l'AGEFI

Selexis SA hires new strategic partners to strengthen its cell line development services

Ferring acquires Rebiotix Inc.

Ferring announces their acquisition of Rebiotix Inc., microbiome pioneer.

ADDEX THERAPEUTICS Sucessfully Raises CHF40 million in Capital Increase

"This is a transformational event for Addex which will enable us to advance our portfolio of allosteric modulator drug candidates through important value inflection points, including completing Phase 3 registration studies for dipraglurant," said Tim Dyer, CEO of Addex

Le Biopôle recrute un/une "Marketing & Communication Manager - 80% “

La personne sélectionnée sera en charge de la stratégie et les actions marcom du Biopôle

MEDTRONIC - Open Innovation Days

Presentation of some of the company’s most advanced manufacturing facilities at Tolochenaz on 3 May 2018

Genomic Health: New Real-World Clinical Practice Data

Genomic Health today announced the presentation of new data with the Oncotype DX® test at the 11th European Breast Cancer Conference (EBCC-11) in Barcelona, Spain

MassChallenge 2018 Accelerator Program

Applications are open until 28 March 2018!

Lunaphore collaborates with PerkinElmer

The Swiss start-up announced on 20 March that it will collaborate with the American multinational corporation to develop staining and analysis solutions for tumor samples.

Discover regenHU's 3DDiscovery Evolution bio-printer

regenHU will launch their new product @ the IDTechEX Show on 11-12 April 2018 in Berlin, Germany.

La 2ème édition d’Orthomanufacture

Fort du succès enregistré à St Etienne en juin dernier, Orthomanufacture récidive à Yverdon-les-Bains les 20 et 21 juin 2018.

Lundbeck to acquire Prexton Therapeutics

This acquisition will add foliglurax in clinical phase II to its pipeline of innovative treatments for patients suffering from Parkinson's disease
Attachment

Le Challenge Debiopharm Inartis

La qualité de vie du patient en cours de traitement

"Qui pourra changer le monde dans lequel nous vivons?”

Luc Stoppini raconte son Prix BioAlps

Prix BioAlps 2017 : la récompense d’une carrière

Glenmark Pharmaceuticals S.A. to invest in new Translational Research Group @ Biopôle

Glenmark Pharmaceuticals announces it will enhance its capabilities in translational research by opening a new discovery centre at the Biopôle campus of Lausanne.

Kick-off Medtech Accelerator at EPFL Innovation Park

Monday 12 March @ 17:30, at room Neptune, Building C of EPFL Innovation Park

Learn more about La Forge's new expert coaching programs for a selection of verticals.

The first vertical acceleration track will be dedicated for Medtech related projects!

Compugen Has Licensed Selexis' Cell Line-Based Protein Expression Platform for the Development of An

Selexis SA announces that Compugen Ltd. has taken a license to the Selexis SUREtechnology Platform™ for use in generating high-performance research cell banks (RCBs).

Selexis SA and Xencor sign 4 Commercial License Agreements

On 26 February, Xencor Signs Four Commercial License Agreements with Selexis SA to Advance its Pipeline of XmAb Bispecific Antibody Drug Candidates

Business offer from a German company represented by the Enterprise Europe Network

A German company, part of the Enterprise Europe Network, specialized in planning and interior fitting of hospitals and veterinary clinics offers sales representation of its products and services world-wide.

UNRAVELLING THE SECRETS OF THE BRAIN

Bilan and BioAlps special webdoc edition

BioAlps Bridging the World : Worldwide Visibility Package 2018

A yearly international programme for our affiliated companies to increase their visibility
Archive:  2018  2017  2016  2015  2014  2013  2012  2011  2010 
Find an actor

4à6 de BioAlps - Ferring29.05.2018

Les "4à6" de BioAlps sont une série d'événements organisés dans chacun des 7 cantons de Suisse occidentale.

Kinntek chooses Pryv

Kinntek, announces that it has chosen Pryv to extend its breakthrough hand rehabilitation interactive platform with...
Print this page Download this page (PDF) Recommend this page to a friend

Contact us

BioAlps Association
Ch. du Pré-Fleuri 3
CH - 1228 Plan-les Ouates
+41 22 304 40 40
+41 22 304 40 70

Subscribe to our newsletter

Find us on LinkedIn